Full Text
Pharmacoeconomic Effectiveness of the Inclusion of Glycopyrronium Bromide into the Program of Reimbursement of Essential Drugs for Patients with COPD

Abstract

Authors

S Zyryanov I Dyakov

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×